Dublin, Sept. 30, 2013 (GLOBE NEWSWIRE) -- Research and Markets
(http://www.researchandmarkets.com/research/4nk3v6/injectable_drug)
has announced the addition of the
"Injectable Drug Delivery to 2018 Drugs, Devices, Targets,
Therapeutics and Forecasts" report to their offering.
The past decade has seen a dramatic shift in terms of the types of
approved injectable drugs, the diseases they target, and the
devices used to deliver them. This shift has fostered change on
several levels of the healthcare sector. The injectable drug
segment has seen a marked increase in the level of drug/device
integration, as prefilled syringes and specialized injection
devices proliferate in response to safety and economic challenges
posed by recombinant protein drugs, while administration of
injectables has moved increasingly from practitioner offices and
healthcare facilities to patient homes.
This report examines the key therapeutic, product, market and
regulatory factors for
injectable drugs across ten major disease and therapeutic
classes, providing essential insight and forecasts into the
implications of this evolving landscape.
Highlights
- Analyzes and evaluates the shifting landscape for injectable drug
delivery and assesses the market impact of new and emerging
injectable drug products by therapeutic indication
- Analyzes syringe and injector device designs,
feature/functionality, product branding, competing technologies and
market development issues
- Provides detailed descriptions of key injectable drug therapeutic
market segments, market demographics, and business strategies
- Forecasts Injectable drug product demand by indication and
therapy to 2018
- Profiles leading injection device companies, their product
development activities, business strategies, and corporate
alliances and affiliations
Key Topics Covered:
Executive Summary
Injectable Drug Delivery Market Dynamics
The Injectable Drug Ecosystem
Injectable Drug Demand Drivers
Drug Development Factors
Market Factors
Technology Factors
Competitive Landscape
Autoinjectors
Needle-free Injectors
Pen Injectors
Prefilled Syringes
Safety Syringes
Injectable Drug Demand Drivers
Diseases and Indications
Patient Demographics
Developing Economies
Risks and Opportunities
Injectable Drug Device Selection Criteria
Stability and Material Selection Issues
Single vs Multi-Dose Devices
Lyophilized Drugs/Reconstitution
Syringe Safety/Sharps Protection
Needle Configuration Strategies
Disposable Drug Cartridges
Human Engineering/Ergonomics
Branding/Private Labeling
Injectable Drug Delivery - Device Segments
Autoinjectors
Autoinjector-specific Selection Factors
Part Counts and Device Cost
Safety Features
Needle Shielding
Needle Insertion Depth
Failsafe Activation
Dose Inspection/Injection Confirmation
Autoinjector Device Categories
Reusable Autoinjectors
Disposable Autoinjectors
Product Specific Autoinjectors
Drugs and Therapeutic Segments
Needle-free Injectors
Device Categories
End User/Practitioner/Mass Immunization Injectors
Prefilled Disposable Models
Refillable Cartridge Designs
Needle-free Injector-specific Selection Factors
Energy Source
Injection Site Selection
Pen Injectors
Pen Injector Device Categories
Standardized Pen Platforms
Custom Pen Designs
Reusable Pens
Prefilled Pen Cartridges
Disposable Pens
Dual Chamber Pens
Branded Drug/Pen Injector Product by Therapeutic Segment
Prefilled Syringes
Prefilled Syringe Device Categories
Glass Prefilled Syringes
Prefillable Glass Syringe Manufacturers and Branded Devices
Branded Drug/Prefilled Glass Syringe Products by Therapeutic
Segment
Plastic Prefilled Syringes
Branded Prefillable Plastic Syringes
Drugs and Therapeutic Segments
Prefillable Safety Syringes
Prefilled Syringe-specific Selection Factors
PFS Manufacturing Factors
Fill-and-Finish Operations
Safety Syringes
Safety Syringe Device Categories
Prefillable Integrated Safety Syringes
Non-Prefillable Integrated Safety Syringes
Retractable Needle
Manually Retractable
Automatic Retractable
Sliding Sheath
Injectable Drug Delivery - Therapeutic Segment Analysis &
Forecasts
Anaphylaxis
Anticoagulants
Antivirals
Autoimmune Diseases
Emergency Medicine
Hematopoietics
Hormone Replacement
Metabolic Diseases
Neurology
Reproductive Health
Vaccines
Injectable Drug Therapeutics - Market Factors
Regulatory Factors and Issues
FDA Regulations
Regulating Combination Products
Sharps Legislations
Growth and Diversity of Safety Syringes
Sharps Disposal
Clinical Trial Factors
Managed Care and Healthcare Economics
Company Profiles
For more information visit
http://www.researchandmarkets.com/research/4nk3v6/injectable_drug
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector:
Drug Delivery